<DOC>
	<DOCNO>NCT00933972</DOCNO>
	<brief_summary>This 4 arm study investigate pharmacodynamics pharmacokinetics RO4998452 type 2 diabetes patient vary degree renal impairment . Eligible patient divide 4 group , normal renal function , mild , moderate severe renal impairment . All patient receive single oral dose RO4998452 fast state.The anticipated time study treatment &lt; 3 month ( single dose study ) target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Study RO4998452 Type 2 Diabetes Patients With Varying Degrees Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>adult patient , 4080 year age ; type 2 diabetes ; normal renal function , impair stable renal function ; stable regard medication treatment regimen take renal impairment diabetes . patient renal transplant ; endstage renal disease , require dialysis ; nephrotic syndrome , history nephrectomy ; type 1 diabetes mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>